Funding for this research was provided by:
Mitacs Accelerate program
Medcan Biotechnologies Inc., Vancouver, British Columbia, Canada
Article History
Received: 26 January 2021
Revised: 1 June 2021
Accepted: 8 June 2021
First Online: 27 June 2021
Declarations
:
: DN is president of Medleaf Biotechnologies and other authors declare that they have no competing interests. The paper is the subject of a PCT application: CA2021050503.
: Not applicable.
: Not applicable.
: Not applicable.